Skip to main content
Top

18-04-2024 | Autoimmune Pancreatitis | Multicenter Seminars: IBD (MUSE: IBD)

A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis

Authors: Kevin Kane, Fernando S. Velayos, Jeffrey K. Lee, Sarah Cherny, Kunal Karia

Published in: Digestive Diseases and Sciences

Login to get access

Excerpt

A previously healthy 36-year-old male was evaluated in the emergency department with two weeks of left-sided abdominal pain and diarrhea. The pain radiated to his back and was associated with poor oral intake and a 25-pound weight loss. Bowel movements numbered 4–5 per day, with urgency and intermittent bleeding. Initial evaluation revealed a normal complete blood count and liver function tests, although lipase 722 U/L (ULN = 90 U/L), CRP 3.5 mg/dL and calprotectin 750 µg/g were elevated. Stool tests were negative for infection (Clostridioides difficile, ova/parasites, Giardia, and bacteria). A CT scan demonstrated peripancreatic fat stranding (Image 1); a right upper quadrant ultrasound was negative for gallstones or biliary dilation (common bile duct = 3 mm). Serum calcium was normal (9.3 mg/dL) as were non-fasting triglycerides (97 mg/dL). He denied alcohol use, recent travel, sick contacts, as well as family history of pancreatitis or inflammatory bowel disease. Genetic testing was negative for cystic fibrosis transmembrane regulator (CFTR), chymotrypsin C (CTRC), human cationic trypsinogen (PRSS)1, and serine protease inhibitor, Kazal-type (SPINK)1 mutations. IgG subclasses showed a normal serum IgG4 level (82.5 mg/dL).
Literature
1.
go back to reference Ball WP, Baggenstoss AH, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol (Chic). 1950;50:347–358.PubMed Ball WP, Baggenstoss AH, Bargen JA. Pancreatic lesions associated with chronic ulcerative colitis. Arch Pathol (Chic). 1950;50:347–358.PubMed
11.
Metadata
Title
A Response-able Diagnosis: Type 2 Autoimmune Pancreatitis in the Setting of Ulcerative Colitis
Authors
Kevin Kane
Fernando S. Velayos
Jeffrey K. Lee
Sarah Cherny
Kunal Karia
Publication date
18-04-2024
Publisher
Springer US
Published in
Digestive Diseases and Sciences
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-024-08408-7
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine